(Total Views: 713)
Posted On: 10/21/2020 6:08:28 PM
Post# of 145247
Very interesting. I previously outlined how I thought leronlimab's disruption of the mTOR pathway could act as an antiviral by stopping viral splitting. Disruption of mTOR also downregulates neuropilin-1. So now we know of 2 and possibly 3 ways leronlimab acts against the virus.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)